ratio < 0.75. The gender, tumour differentiation, epidermal growth factor receptor mutation, smoking habits, lymphovascular space invasion, tumour size, maximum standard uptake value and carcinoembryonic antigen levels were significantly different in the 2 groups. In thegroup with a GGO ratio >0.75, 63.3% of the patients underwent sublobar resection (18.8% with a GGO ratio < 0.75, P < 0.001). These patientshad fewer relapses (2.2% for GGO ratio >0.75, 26.8% for GGO ratio < 0.75, P < 0.001) and a better 5-year survival rate (95.5% for GGO ratio>0.75, 77.4% for GGO ratio < 0.75, P < 0.001). None of the patients with a GGO ratio >0.75 had lymph node involvement. The multivariable Cox regression analysis revealed that a GGO ratio < 0.75 was an independent factor for postoperative relapse with a hazard ratio of 3.96.
prediction in patients with resected lung adenocarcinoma. Sublobarresection and lymph node sampling revealed a fair outcome regardless of tumour size. However, anatomical resection is still the standard approach for patients with tumours with a GGO ratio < 0.75, size >2 cm. Osaka University, Japan Background and Aims: Lung cancer is the world's leading cause of cancer death. Early detection of lung cancer is quite limited because of the lack of sensitive and specific biomarkers. Lung cancer conducts cell proliferation and invasion through aberrant protease activity. The aberrant protease activity induces protein fragments from cancer tissues and the fragments have potential as detection markers of lung cancer. In the present study, we focused on the exploration of lung adenocarcinoma specific C-terminal protein fragment in urine by using iTRAQ method and multiple reaction monitoring (MRM) method which are methods used in tandem mass spectrometry.
Methods:
We comprehensively analyzed the structure of C-terminal protein fragments in the urine from 24 patients with early stage lung adenocarcinoma and 25 healthy controls by iTRAQ method. We quantified the amount of the C-terminal protein fragments in the urine from 26 patients with stage I lung adenocarcinoma and 40 healthy controls by MRM method. We investigated the amount of C-terminal protein fragments in lung cancer tissues and lung adenocarcinoma cell lines (HLC-1, A549 and PC-9) by western blotting and evaluated the diagnosis capability of the fragments in serum by ELISA.
Results: In iTRAQ analyses, we discovered a fragment of α-1-microglobulin/bikunin precursor (AMBP) as an early diagnostic marker of lung adenocarcinoma. The expression levels of the AMBP fragment in lung adenocarcinoma tissues and lung cancer cell lines are higher than those of levels in normal lung tissues and BEAS-2B cells. The AUC value of the AMBP fragment levels in urine determined by MRM method for detection of stage I adenocarcinoma was higher than that of the serum CEA. The AUC for C-terminal AMBP levels determined by ELISA is also higher than that of CEA. Methods: Our previous study indicates that CAP1 is overexpressed in NSCLC tissues and correlated with poor clinical outcomes. Further establishing the role and dissecting underlying mechanisms are imperative before targeting CAP1 can become a possibility for cancer treatment.
Conclusion
Results: Here we report our findings that knockdown of CAP1 inhibited cell proliferation and induced apoptosis in vitro and in vivo. Moreover, Phosphor mutants of CAP1 at the S307/S309 regulatory site had compromised rescue effects for both the invasiveness and proliferation in CAP1-knockdown cells and GSK3β kinase inhibitor Licl inhibits cell phosphorylation site S307/S309 by up-regulating the expression of p53, BAK, Bad and cleaved PARP induced ROS production, decreased lung cancer cell viability, adhesion, proliferation, migration and Invasion, induction of apoptosis. 

